The first large-scale genetic study of E. coli's protective armor has identified the five capsule types that are responsible for 70% of all multidrug-resistant bloodstream infections in Europe. Researchers, including those at the Wellcome Sanger Institute, the University of Oslo, and their collaborators, analyzed over 18,000 bacterial genomes from samples across all continents to investigate E. coli's armor and find new ways to penetrate it.
